<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We tested an in vitro system simulating <z:mp ids='MP_0001914'>bleeding</z:mp> time reported by Kratzer et al </plain></SENT>
<SENT sid="1" pm="."><plain>Primary hemostasis was studied perfusing an artificial vessel with citrated blood under a constant pressure of 40 mmHg, measuring the blood volume perfused (<z:mp ids='MP_0001914'>bleeding</z:mp> volume) and the time until blood flow stopped (<z:mp ids='MP_0001914'>bleeding</z:mp> time) </plain></SENT>
<SENT sid="2" pm="."><plain>The artificial vessel consists of a glass capillary simulating arteriole and a filter covered with collagen type I to provide a surface for the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of platelets </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:mp ids='MP_0001914'>bleeding</z:mp> volume (mean +/- SD microliters) was 317.7 +/- 93.8 in controls (n = 19), 487.3 +/- 242.1 in <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo> (n = 9), 666.8 +/- 224.1 in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (n = 4), greater than 820 in <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand's disease</z:e> (n = 3), 231.0 +/- 74.5 in <z:e sem="disease" ids="C0684275,C0019069" disease_type="Disease or Syndrome" abbrv="">hemophilia</z:e> A (n = 3), 499.0 +/- 269.4 in liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> (n = 6), and 457.7 +/- 229.0 in <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (n = 11) </plain></SENT>
<SENT sid="4" pm="."><plain>When citrated blood was applied to this system after incubation with monoclonal antibodies (MoAb) to <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor or platelet membrane <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> Ib (GPIb), <z:mp ids='MP_0001914'>bleeding</z:mp> volume was significantly increased while no effects were observed after incubation with MoAb to GPIIb/IIIa, factor VIII: CAg and factor XIIIa </plain></SENT>
<SENT sid="5" pm="."><plain>These data suggest that in vitro model of primary hemostasis could be used for not only diagnosing <z:mp ids='MP_0001914'>bleeding</z:mp> disorders although 'time' is not reliable, but also investigating the mechanisms of hemostasis </plain></SENT>
</text></document>